Lunit’s SCOPE AI tools demonstrate value in HER2 biomarker evaluation
A new study has demonstrated the value of Lunit’s AI-powered pathology tools in improving human epidermal growth factor receptor 2 …
Post
-
-
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics …
-
Vantis Vascular completes first commercial use of CrossFAST system
Vantis Vascular has completed the first commercial application of its CrossFAST Integrated Microcatheter Advanced Delivery System. The procedures were carried out …
-
Leica partners with Molecular Instruments for fluorescent RNA assay integration
Leica Biosystems has partnered with Molecular Instruments (MI) to integrate its imaging assay with Leica’s BOND series of research staining …
-
What is the Stargate project and why does it matter?
The Stargate project announcement on OpenAI’s website ends with a call for collaboration with companies “across the built data centre …
-
Mayo Clinic joins SeaStar Medical for acute kidney injury trial
Mayo Clinic has joined SeaStar Medical as the 15th site authorised to enrol subjects for the company’s pivotal NEUTRALIZE-AKI trial …
-
Trump’s trade, tech wars to hit ‘businesses in all sectors all over the world’
The trade and tech wars that Donald Trump is expected to unleash as central pillars of his second US presidency …
-
Roche’s STI assay panels gain FDA 510(k) clearance and CLIA waiver
Roche has received 510(k) clearance with a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver from the US Food and …
-
Aivas: a new supercomputer to support AI software deployment in healthcare
The use of AI and generative AI (genAI) applications to speed up diagnosis and unlock new insights for medical imaging …
-
China to remain a headwind in 2025 for J&J MedTech, CFO says
Johnson & Johnson (J&J) MedTech has reported a 4.8% growth in global sales in 2024, though it expects its 2025 …
-
Tempus launches AI healthcare data consolidation app
Tempus AI has launched olivia in the US, an app designed for centralising patient healthcare data onto a unified platform …
-
Carilion to use BD’s needle-free blood draw device
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging Becton, Dickinson and Company’s (BD) …
-
AdventHealth partners Biofourmis to advance whole-person care at home
AdventHealth has partnered with Biofourmis to introduce the AdventHealth Hospital at Home programme, which offers inpatient-level care to patients within …
-
FDA grants MRI conditional label extension for Nalu Medical’s neurostimulation system
The US Food and Drug Administration (FDA) has granted an extended label clearance for whole-body MRI-conditional use to Nalu Medical’s …
-
Exact Sciences post positive results from MRD trial
Exact Sciences, has shared results from a trial of its Oncodetect test which is designed to identify the last remaining …
